Department of Endocrinology, Diabetes and Metabolism, Elena Venizelou Hospital, GR-11521 Athens, Greece.
Division of Endocrinology, Department of Internal Medicine, School of Health Sciences, University of Patras, GR-26504 Patras, Greece.
Med Sci (Basel). 2024 Sep 27;12(4):50. doi: 10.3390/medsci12040050.
INTRODUCTION/AIM: Central sensitivity to thyroid hormones refers to the responsiveness of the hypothalamic-pituitary-thyroid (HPT) axis to changes in circulating free thyroxine (fT4). Although dose-response relationships between thyroid hormones per se and urinary iodine (UI) levels have been observed, central sensitivity to thyroid hormones in relation to UI remains unexplored. The aim of the present study was to evaluate central sensitivity to thyroid hormones (by means of the Thyroid Feedback Quantile-based Index [TFQI], which is a calculated measure, based on TSH and fT4, that estimates central sensitivity to thyroid hormones) in pregnancy and to assess whether it differs according to gestational age and/or iodine intake.
One thousand, one hundred and two blood and urine samples were collected from pregnant women (with a mean age ± SD of 30.4 ± 4.6 years) during singleton pregnancies; women with known/diagnosed thyroid disease were excluded. Specifically, TSH and fT4, anti-thyroid peroxidase antibodies and UI were measured in each trimester and at two months postpartum, while the TFQI was calculated for all the study samples. After the elimination of outliers, statistical analysis was conducted with analysis of variance (ANOVA) for the variables versus time period, while Pearson's correlation was used to assess the TFQI versus UI.
The mean TFQI index ranged from -0.060 (second trimester) to -0.053 (two months postpartum), while the corresponding UI was 137 and 165 μg/L, respectively. The TFQI-UI correlation was marginally negative (Pearson r: -0.323, : 0.04) and significantly positive (r: +0.368, : 0.050) for UI values over 250 μg/L, in the first and the second trimesters of pregnancy, respectively.
The TFQI is a new index reflecting central sensitivity to thyroid hormones. A lower TFQI indicates higher sensitivity to thyroid hormones. In our sample, the TFQI was mainly positively related to iodine intake in the second trimester of pregnancy (following the critical period of organogenesis). Thus, the observed changes in the TFQI may reflect the different ways of the central action of thyroid hormones, according to the phase of pregnancy. These results have the potential to enhance our comprehension of the changes in the HPT axis' function via variations in central sensitivity to thyroid hormones and its interplay with nutritional iodine status during pregnancy.
简介/目的:甲状腺激素的中枢敏感性是指下丘脑-垂体-甲状腺(HPT)轴对循环游离甲状腺素(fT4)变化的反应性。尽管已经观察到甲状腺激素本身与尿碘(UI)水平之间的剂量反应关系,但甲状腺激素的中枢敏感性与 UI 之间的关系仍未得到探索。本研究的目的是评估妊娠期间甲状腺激素的中枢敏感性(通过甲状腺反馈定量指数[TFQI]来评估,TFQI 是一种基于 TSH 和 fT4 的计算指标,可估计甲状腺激素的中枢敏感性),并评估其是否因孕龄和/或碘摄入量而异。
从 1102 名单胎妊娠的孕妇中采集了 1102 份血液和尿液样本(平均年龄 ± SD 为 30.4 ± 4.6 岁);排除了已知/诊断为甲状腺疾病的妇女。具体而言,在每个孕早期和孕晚期以及产后两个月测量 TSH 和 fT4、抗甲状腺过氧化物酶抗体和 UI,同时为所有研究样本计算 TFQI。在消除异常值后,使用方差分析(ANOVA)对变量与时间段进行了统计分析,而 Pearson 相关性用于评估 TFQI 与 UI 的关系。
平均 TFQI 指数范围为-0.060(孕中期)至-0.053(产后两个月),相应的 UI 分别为 137 和 165μg/L。TFQI-UI 相关性在孕早期和孕晚期的 UI 值分别为 250μg/L 以上时呈负相关(Pearson r:-0.323,:0.04)和正相关(r:+0.368,:0.050)。
TFQI 是一种反映甲状腺激素中枢敏感性的新指标。较低的 TFQI 表示对甲状腺激素的敏感性更高。在我们的样本中,TFQI 主要与妊娠中期(器官发生关键期之后)的碘摄入量呈正相关。因此,观察到的 TFQI 变化可能反映了甲状腺激素的中枢作用方式的不同,这取决于妊娠的阶段。这些结果有可能通过研究甲状腺激素的中枢敏感性变化及其与妊娠期间营养碘状态的相互作用,增强我们对 HPT 轴功能变化的理解。